This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Wettbewerbsrechtliche Überprüfbarkeit der Fachinformation eines Arzneimittels und Reichweite der Legitimationswirkung der Arzneimittelzulassung

January 20, 2016 , juris-Praxisreport Medizinrecht (Case note on legal options to challenge a competitor drug's SmPC and the scope of a marketing authorisation's legal protection), Author

Share this article: